Ignite Creation Date:
2024-05-05 @ 11:41 AM
Last Modification Date:
2024-10-26 @ 9:11 AM
Study NCT ID:
NCT00100126
Status:
COMPLETED
Last Update Posted:
2006-10-25
First Post:
2004-12-23
Brief Title:
APC-231 Once a Day QD for 7 Days vs Penicillin Taken Four Times a Day QID in Pediatric Patients With Strep Throat
Sponsor:
Advancis Pharmaceutical Corporation
Organization:
Advancis Pharmaceutical Corporation
Study Overview
Official Title:
A Phase III Investigator Blind Randomized Multicenter Study to Evaluate the Efficacy and Safety of APC-231 Sprinkle QD for 7 Days vs Penicillin VK 10 mgkg QID for 10 Days in Pediatric Patients With Streptococcus Pyogenes
Status:
COMPLETED
Status Verified Date:
2005-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The purpose of this study is to evaluate the efficacy and safety of APC-231 QD for 7 days in the bacteriological outcome at the Test of Cure Visit
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None